Clinical trial
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers…
NCT00417820 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00417820 |
|---|---|
| Title | Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis. |
| Official title | A Multicenter, Double-Blind, Placebo Controlled Exploratory Study to Evaluate the Safety, Tolerability and Pharmacodynamics of a Single Administration of BCT194 in Healthy Volunteers and Multiple Administrations in Patients With Psoriasis. |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | BCT194 |
| Enrollment | 35 |
| Start date | Nov 1, 2006 |
| Completion | Nov 1, 2007 |
| First posted | Jan 4, 2007 |
| Last update posted | Nov 29, 2007 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: